...acromegaly, Nutropin AQ for growth failure, Increlex mecasermin for growth delay and cancer therapy Decapeptyl triptorelin pamoate...

...acromegaly, Nutropin AQ for growth failure, Increlex mecasermin for growth delay and cancer therapy Decapeptyl triptorelin pamoate...

...LLC , Atlanta, Ga. Debiopharm Group , Lausanne, Switzerland Product: Triptodur triptorelin Business: Endocrine/Metabolic Julian Zhu Debio 8206 SC Decapeptyl Triptorelin triptorelin pamoate Arbor...

...ovarian cancer has only three: the VEGF inhibitor Avastin bevacizumab; the GnRH/LHRH receptor agonist Decapeptyl triptorelin pamoate...

...The U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA) approved a label expansion for Decapeptyl triptorelin pamoate...
...of recurrence or who are confirmed premenopausal after completion of chemotherapy. The controlled-release formulation of triptorelin pamoate...
...and endometriosis. Ipsen Group (Euronext:IPN; Pink:IPSEY), Boulogne-Billancourt, France Product: Decapeptyl triptorelin pamoate (Trelstar) (Debio 8206) Business: Cancer Julian Zhu Debio 8206 Decapeptyl Trelstar triptorelin pamoate Ipsen...

...following approval in Italy. Xbrane said the product, which is a slow-release formulation of Decapeptyl triptorelin pamoate...

...patients with CPP showed that 2 intramuscular injections of a 6-month formulation of 22.5 mg triptorelin pamoate...
...of the product as Trelstar to treat advanced prostate cancer. Ipsen, which has rights to triptorelin pamoate...
...Switzerland Ipsen Group (Euronext:IPN; Pink:IPSEY), Boulogne-Billancourt, France Actavis plc , Dublin, Ireland Product: Triptorelin pamoate ( Debio 8206...

...Specialty Pharmaceuticals Co. subsidiary and Debiopharm launched a six-month dosing option of 22.5 mg Trelstar triptorelin pamoate...
...U.S. and Canadian rights to the product from Debiopharm. Trelstar is a controlled-release formulation of triptorelin pamoate...

...locally advanced or metastatic prostate cancer showed that a 3-month formulation of 11.25 mg subcutaneous Decapeptyl...
...of the product as Trelstar to treat advanced prostate cancer. Ipsen, which has rights to triptorelin pamoate...
...Ipsen Group (Euronext:IPN; Pink:IPSEY), Boulogne-Billancourt, France Actavis plc (NYSE:ACT), Dublin, Ireland Product: Decapeptyl triptorelin pamoate ( Debio 8206...

...agonist - is also approved as Trelstar in the U.S. for prostate cancer and as Decapeptyl...